JENNIFER SABUDA: Open Payments
NPI 1174830236 · MERRILLVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,761 in 77 payments from 34 companies in 2025. Trend: 2023 $233 · 2024 $782 · 2025 $1,761
Food & beverage: $1,761
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $187 |
| AstraZeneca Pharmaceuticals LP | 7 | $149 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| Stryker Corporation | 2 | $102 |
| Janssen Biotech, Inc. | 4 | $91 |
| Celgene Corporation | 4 | $83 |
| ABBVIE INC. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $75 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $66 |
Products named: KISQALI, KEYTRUDA, AUGMENT INJECTABLE, REBLOZYL, ENHERTU, JEMPERLI, OPDIVO, Amtagvi.
Industry payments across IN — which companies pay providers there.
